Streetbeat News

Analyst Ratings

SABS

SAB Biotherapeutics (NASDAQ:SABS) has received four bullish analyst ratings in the last quarter, with an average price target of $3.25, indicating a potential upside from the current price of $0.755. This average price target has decreased by 18.75% from the previous average of $4.00.

Portfolio Pulse from Benzinga Insights

August 21, 2023 | 6:00 pm

CAG

Analysts have provided mixed ratings for Conagra Brands (NYSE:CAG) within the last quarter, with 1 somewhat bullish and 5 indifferent. The average price target is $37.5, implying an upside from the current price of $29.62. This average has decreased by 9.27% from the previous average price target of $41.33.

Portfolio Pulse from Benzinga Insights

August 21, 2023 | 6:00 pm

REGN

Regeneron Pharmaceuticals' stock price is increasing following multiple analysts raising their price targets on the stock.

Portfolio Pulse from Benzinga Newsdesk

August 21, 2023 | 5:48 pm

WMS

KeyBanc Capital Markets analyst Jeffrey D. Hammond has reiterated an Overweight rating on Advanced Drainage Systems, Inc. (NYSE:WMS), raising the price target to $160 from $150. Hammond believes that Advanced Drainage's price/cost will benefit from sustained tailwinds from relaxing supply chain friction costs. He also sees an upside beyond the current guidance range, supported by the continued rise in concrete prices and falling resin pricing. For FY24, Hammond expects the company's revenues to be $2.70 billion, with $815.1 million EBITDA.

Portfolio Pulse from Nabaparna Bhattacharya

August 21, 2023 | 5:45 pm

TGT

Target's (NYSE:TGT) short percent of float has fallen 4.27% since its last report, with 9.29 million shares sold short, which is 2.02% of all regular shares available for trading. It would take traders 2.21 days to cover their short positions on average. Target's short interest is less than its peer group average of 3.18%.

Portfolio Pulse from Benzinga Insights

August 21, 2023 | 5:45 pm

AMGN

Amgen's (NYSE:AMGN) short percent of float has fallen 8.96% since its last report, with 6.51 million shares sold short, which is 1.22% of all regular shares available for trading. This decrease in short interest could signal a more bullish market sentiment towards Amgen. Compared to its peers, Amgen has less short interest as a percentage of float, with an average of 3.21%.

Portfolio Pulse from Benzinga Insights

August 21, 2023 | 5:45 pm

WDAY

Workday's (NYSE:WDAY) short percent of float has risen 5.83% since its last report, with 4.45 million shares sold short, which is 2.18% of all regular shares available for trading. It would take traders 2.23 days to cover their short positions on average. An increase in short interest can signal that investors have become more bearish. Workday's peer group average for short interest as a percentage of float is 3.16%, which means the company has less short interest than most of its peers.

Portfolio Pulse from Benzinga Insights

August 21, 2023 | 5:45 pm

APPF

Stephens & Co. analyst John Campbell upgraded AppFolio Inc (NASDAQ:APPF) to Overweight from Equal-Weight and increased the price target to $212 from $184. The analyst is optimistic about the company's leadership change and recent actions to boost margin. He also revised FY23 estimates for revenue and adjusted EPS upwards. APPF shares are up 11.15% at $185.57.

Portfolio Pulse from Lekha Gupta

August 21, 2023 | 5:44 pm

MCD

A significant amount of unusual options activity has been observed for McDonald's (NYSE:MCD), with a majority of investors taking a bearish stance. The trades range from $225.0 to $300.0 for McDonald's over the last 3 months. The price of MCD is currently down -0.74% at $279.66. Several experts maintain an Outperform rating on McDonald's, with price targets ranging from $330 to $345.

Portfolio Pulse from Benzinga Insights

August 21, 2023 | 5:30 pm

NVDA

PATH

TSLA

TWLO

Ark Invest, led by Cathie Wood, suggests that Nvidia's reign as the go-to AI investment may be waning due to its high valuation. Ark Invest is signaling investors to look at small-cap companies instead. The report highlights that mega-cap technology stocks saw a rally on the excitement surrounding AI possibilities, but this might be the wrong move for traders. Ark's favorite AI-related stocks include Tesla, UiPath, and Twilio.

Portfolio Pulse from Chris Katje

August 21, 2023 | 5:20 pm